Mulberry Biotherapeutics
PrivateLast Round
M&A
Oct 1, 2025
Company Overview
Mulberry Biotherapeutics operates in Healthcare & Life Sciences and is based in Wellesley, Massachusetts. Its latest recorded funding round was a VC Round in April 2021.
Mulberry Biotherapeutics is a biotechnology company developing bacteria-mediated immunotherapies for the treatment of rare, slow-growing tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mulberry Biotherapeutics Comparables
Compare Mulberry Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Santo Therapeutics | 78% | |
| Recursion Pharmaceuticals | 78% | |
| Guangzhou Sinogen Pharmaceutical Co., Ltd. | 78% |
For institutional investors. Book with your work email.
Mulberry Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Oct 1, 2025 | ||||
| VC Round | Apr 20, 2021 |
For institutional investors. Book with your work email.
Mulberry Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Community Impact Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 6106% MoM, from 16 to 993.
- Apr 20, 2021
Secured funding from Community Impact Ventures.
For institutional investors. Book with your work email.
Mulberry Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mulberry Biotherapeutics's valuation, stock price, and market status.
Is Mulberry Biotherapeutics a public or private company?
Mulberry Biotherapeutics is a private company.
What is the current stock price of Mulberry Biotherapeutics?
Mulberry Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks Mulberry Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mulberry Biotherapeutics worth (valuation)?
Valuation information for Mulberry Biotherapeutics is not publicly available.
Can I buy Mulberry Biotherapeutics stock?
Mulberry Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mulberry Biotherapeutics's last funding round?
Mulberry Biotherapeutics's most recent funding round was M&A on October 1, 2025.
Who are the main investors in Mulberry Biotherapeutics?
Key investors in Mulberry Biotherapeutics include Community Impact Ventures.
Will Mulberry Biotherapeutics IPO soon?
No public IPO plans have been announced for Mulberry Biotherapeutics.
How can I track Mulberry Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Mulberry Biotherapeutics's shares on secondary markets.